Literature DB >> 28939087

MicroRNA Replacement: A New Era of Molecular Therapy for Tendon Disorders?

Stephanie G Dakin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28939087      PMCID： PMC5628930          DOI： 10.1016/j.ymthe.2017.09.004

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

Review 1.  The pathogenesis of tendinopathy. A molecular perspective.

Authors:  G Riley
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

2.  Genetic influences in the progression of tears of the rotator cuff.

Authors:  S E Gwilym; B Watkins; C D Cooper; P Harvie; S Auplish; T C B Pollard; J L Rees; A J Carr
Journal:  J Bone Joint Surg Br       Date:  2009-07

3.  Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity.

Authors:  Jayesh Dudhia; Charlotte M Scott; Edward R C Draper; Dick Heinegård; Andrew A Pitsillides; Roger K Smith
Journal:  Aging Cell       Date:  2007-06-18       Impact factor: 9.304

Review 4.  Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature.

Authors:  L C Almekinders; J D Temple
Journal:  Med Sci Sports Exerc       Date:  1998-08       Impact factor: 5.411

5.  MicroRNA29a Treatment Improves Early Tendon Injury.

Authors:  Ashlee E Watts; Neal L Millar; Josh Platt; Susan M Kitson; Moeed Akbar; Raquel Rech; Jay Griffin; Roy Pool; Tom Hughes; Iain B McInnes; Derek S Gilchrist
Journal:  Mol Ther       Date:  2017-07-28       Impact factor: 11.454

6.  Inflammation activation and resolution in human tendon disease.

Authors:  Stephanie G Dakin; Fernando O Martinez; Clarence Yapp; Graham Wells; Udo Oppermann; Benjamin J F Dean; Richard D J Smith; Kim Wheway; Bridget Watkins; Lucy Roche; Andrew J Carr
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

Review 7.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

Review 8.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Authors:  Gloria Bertoli; Claudia Cava; Isabella Castiglioni
Journal:  Theranostics       Date:  2015-07-13       Impact factor: 11.556

9.  MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease.

Authors:  Neal L Millar; Derek S Gilchrist; Moeed Akbar; James H Reilly; Shauna C Kerr; Abigail L Campbell; George A C Murrell; Foo Y Liew; Mariola Kurowska-Stolarska; Iain B McInnes
Journal:  Nat Commun       Date:  2015-04-10       Impact factor: 14.919

10.  Lack of tissue renewal in human adult Achilles tendon is revealed by nuclear bomb (14)C.

Authors:  Katja Maria Heinemeier; Peter Schjerling; Jan Heinemeier; Stig Peter Magnusson; Michael Kjaer
Journal:  FASEB J       Date:  2013-02-11       Impact factor: 5.191
View more
  2 in total

Review 1.  Skeletal Muscle Wasting and Its Relationship With Osteoarthritis: a Mini-Review of Mechanisms and Current Interventions.

Authors:  Emily Shorter; Anthony J Sannicandro; Blandine Poulet; Katarzyna Goljanek-Whysall
Journal:  Curr Rheumatol Rep       Date:  2019-06-15       Impact factor: 4.592

2.  Exosomes derived from magnetically actuated bone mesenchymal stem cells promote tendon-bone healing through the miR-21-5p/SMAD7 pathway.

Authors:  Xiang-Dong Wu; Lin Kang; Jingjing Tian; Yuanhao Wu; Yue Huang; Jieying Liu; Hai Wang; Guixing Qiu; Zhihong Wu
Journal:  Mater Today Bio       Date:  2022-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.